Aβ plaques and p-Tau lesions are the hallmarks of AD pathogenesis, but are also seen in normal aging and in other pathogenic processes, such as chronic traumatic encephalopathy (CTE) and substance use disorders [85,86]. Here, MAPT is linked to Alzheimer disease.